Long-term Extension From RCC Phase II (11515)

Clinical trial NCT00586495 · COMPLETED

Trial details

NCT number: NCT00586495
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2005-12-01
Primary completion: 2008-06-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.